EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hepatitis C virus (HCV) proteases: structure, function and inhibition strategies

Pedro Henrique Oliveira Borges, Emmanuel Gras, Sabrina Baptista Ferreira, Floriano Paes Silva

The Enzymes · 2025

DOI: 10.1016/bs.enz.2025.06.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Enzymes, 2025. Verfasst von Pedro Henrique Oliveira Borges und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Síntese e Prospecção Biológica (LaSOPB), Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Hepacivirus, Antiviral Agents, Viral Nonstructural Proteins, Protease Inhibitors. Die Arbeit nennt 107 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) is a bloodborne, hepatotropic RNA virus and a serious global health burden, infecting over 50 million people worldwide, with the majority residing in low- and middle-income countries (LMICs), that significantly contributes to chronic liver diseases like cirrhosis and hepatocellular carcinoma. While no vaccines are available for HCV yet, over the years the success of direct-acting antivirals (DAAs) has been contributing with improved cure rates among treatment-naïve and treatment-experienced patients. However, many challenges remain due to undiagnosed infections and limited access to DAAs in LMICs. Thus, understanding of the molecular biology of HCV is pivotal in driving therapeutic advances, particularly the characterization of its two major proteases: the NS2/3 protease, a cysteine protease responsible for the first cleavage event of the polyprotein; and the NS3/4A protease, a serine protease that cleaves the remainder of the HCV genome. These proteases have been extensively studied as drug targets, although there is still much to learn. The NS3/4A protease has been a validated target for the development of DAAs, with several FDA-approved drugs in recent years. Yet, many challenges remain, as the genetic diversity of HCV has been leading to the emergence of drug-resistant strains that require the administration of the costly pan-genotypic DAAs. In this chapter we explore the structure and functions of NS2/3 and NS3/4A in the viral life cycle, how DAAs engage such targets and which mutations drive resistance. We conclude by discussing future and even less explored approaches in hopes of contributing to the current HCV drug development scenario.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusAntiviral AgentsViral Nonstructural ProteinsProtease InhibitorsHumansHepatitis CSerine ProteasesSerine EndopeptidasesNucleoside-TriphosphataseDEAD-box RNA HelicasesViral Proteases

Stichwörter der Autor:innen

Direct-acting antiviralsDrug resistanceNs2/3 proteaseNs3/4a protease

Substanzen

Antiviral AgentsViral Nonstructural ProteinsProtease InhibitorsNS3 protein, hepatitis C virusNS3-4A serine protease, Hepatitis C virusSerine ProteasesSerine EndopeptidasesNucleoside-TriphosphataseDEAD-box RNA HelicasesViral Proteases

Autor:innen und Institutionen

  • Laboratório de Síntese e Prospecção Biológica (LaSOPB), Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • LHFA, Université de Toulouse, CNRS, Toulouse, France.
  • Laboratório de Bioquímica Experimental e Computacional de Fármacos (LaBECFar), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Borges, P. H. O., Gras, E., Ferreira, S. B., & Paes Silva, F. (2025). Hepatitis C virus (HCV) proteases: structure, function and inhibition strategies. The Enzymes. https://doi.org/10.1016/bs.enz.2025.06.003

Vancouver

Borges PHO, Gras E, Ferreira SB, Paes Silva F. Hepatitis C virus (HCV) proteases: structure, function and inhibition strategies. The Enzymes. 2025. doi:10.1016/bs.enz.2025.06.003

BibTeX
@article{Borges2025,
  author = {Borges, Pedro Henrique Oliveira and Gras, Emmanuel and Ferreira, Sabrina Baptista and Paes Silva, Floriano},
  title = {Hepatitis C virus (HCV) proteases: structure, function and inhibition strategies},
  journal = {The Enzymes},
  year = {2025},
  doi = {10.1016/bs.enz.2025.06.003}
}
Kostenlos starten →